Wenting-van Wijk MJ - Search Results

1

Accumulation of advanced glycation end products as a molecular mechanism for aging as a risk factor in osteoarthritis.

DeGroot J, Verzijl N, Wenting-van Wijk MJ, Jacobs KM, Van El B, Van Roermund PM, Bank RA, Bijlsma JW, TeKoppele JM, Lafeber FP. DeGroot J, et al. Among authors: wenting van wijk mj. Arthritis Rheum. 2004 Apr;50(4):1207-15. doi: 10.1002/art.20170. Arthritis Rheum. 2004. PMID: 15077303 Free article.

2

DeGroot J, Verzijl N, Wenting-Van Wijk MJ, Bank RA, Lafeber FP, Bijlsma JW, TeKoppele JM. DeGroot J, et al. Among authors: wenting van wijk mj. Arthritis Rheum. 2001 Nov;44(11):2562-71. doi: 10.1002/1529-0131(200111)44:11<2562::aid-art437>3.0.co;2-1. Arthritis Rheum. 2001. PMID: 11710713 Free article.

3

Increased expression of interleukin-7 in labial salivary glands of patients with primary Sjögren's syndrome correlates with increased inflammation.

Bikker A, van Woerkom JM, Kruize AA, Wenting-van Wijk M, de Jager W, Bijlsma JW, Lafeber FP, van Roon JA. Bikker A, et al. Arthritis Rheum. 2010 Apr;62(4):969-77. doi: 10.1002/art.27318. Arthritis Rheum. 2010. PMID: 20131250 Free article.

4

Elevated expression of interleukin-7 receptor in inflamed joints mediates interleukin-7-induced immune activation in rheumatoid arthritis.

Hartgring SA, van Roon JA, Wenting-van Wijk M, Jacobs KM, Jahangier ZN, Willis CR, Bijlsma JW, Lafeber FP. Hartgring SA, et al. Arthritis Rheum. 2009 Sep;60(9):2595-605. doi: 10.1002/art.24754. Arthritis Rheum. 2009. PMID: 19714586 Free article.

5

Persistence of interleukin 7 activity and levels on tumour necrosis factor alpha blockade in patients with rheumatoid arthritis.

van Roon JA, Hartgring SA, Wenting-van Wijk M, Jacobs KM, Tak PP, Bijlsma JW, Lafeber FP. van Roon JA, et al. Ann Rheum Dis. 2007 May;66(5):664-9. doi: 10.1136/ard.2006.062547. Epub 2006 Dec 21. Ann Rheum Dis. 2007. PMID: 17185327 Free PMC article.

6

Relation of plasma dexamethasone to clinical response.

Wenting-Van Wijk MJ, Blankenstein MA, Lafeber FP, Bijlsma JW. Wenting-Van Wijk MJ, et al. Clin Exp Rheumatol. 1999 May-Jun;17(3):305-12. Clin Exp Rheumatol. 1999. PMID: 10410263

7

Salivary gland and peripheral blood T helper 1 and 2 cell activity in Sjögren's syndrome compared with non-Sjögren's sicca syndrome.

van Woerkom JM, Kruize AA, Wenting-van Wijk MJ, Knol E, Bihari IC, Jacobs JW, Bijlsma JW, Lafeber FP, van Roon JA. van Woerkom JM, et al. Among authors: wenting van wijk mj. Ann Rheum Dis. 2005 Oct;64(10):1474-9. doi: 10.1136/ard.2004.031781. Epub 2005 Apr 7. Ann Rheum Dis. 2005. PMID: 15817659 Free PMC article.

8

Increased immune reactivity towards human hsp60 in patients with primary Sjögren's syndrome is associated with increased cytokine levels and glandular inflammation.

de Jong H, de Jager W, Wenting-van Wijk M, Prakken BJ, Kruize AA, Bijlsma JW, Lafeber FP, van Roon JA. de Jong H, et al. Clin Exp Rheumatol. 2012 Jul-Aug;30(4):594-5. Epub 2012 Aug 29. Clin Exp Rheumatol. 2012. PMID: 22931585 No abstract available.

9

Decreased expression of thymic stromal lymphopoietin in salivary glands of patients with primary Sjögren's syndrome is associated with increased disease activity.

Hillen MR, Kruize AA, Bikker A, Wenting-van Wijk M, Radstake TR, Hack CE, Lafeber FP, van Roon JA. Hillen MR, et al. Mod Rheumatol. 2016;26(1):105-9. doi: 10.3109/14397595.2015.1054089. Epub 2015 Sep 23. Mod Rheumatol. 2016. PMID: 25995032

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

9 results

Search Page

Filters